Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 2, 2016, Pages

  Crawford, Tineke J ^a   Crowther, Caroline A ^a,b   Alsweiler, Jane ^c   Brown, Julie ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL;

CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE COST; HIGH RISK PREGNANCY; HUMAN; LONG TERM CARE; MATERNAL CARE; MOTHER FETUS RELATIONSHIP; MULTIPLE PREGNANCY; NEWBORN CARE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERINATAL MORTALITY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROGENY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84969540895     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012048     Document Type: Review

References (37)

1. American College of Obstetricians and Gynecologists. Gestational Diabetes Mellitus: Practice Bulletin Number 137. Obstetrics and Gynecology 2013;122(2 Pt 1):406-16.
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2013;36(Suppl 1):S11-S66.
3. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus. Part 1: Diagnosis and classification of diabetes mellitus: World Health Organization Report. Diabetic Medicine 1998;15(7):539-53.
4. Alwan N, Tuffnell D, West J. Treatments for gestational diabetes. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2]
5. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115(3):e290-6.
6. Carlomagno G, Unfer V, Buffo S, D'Ambrosio F. Myo-inositol in the treatment of premenstrual dysphoric disorder. Human Psychopharmacology: Clinical and Experimental 2011;26(7):526-30.
7. Catalano P, Thomas A, Huston-Presley L, Amini S. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. American Journal of Obstetrics and Gynecology 2003;189(6):1698-704.
8. Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes 2008;32(Suppl 1):S1-S201.
9. Clements RS, Darnell B. Myo-inositol content of common foods: development of a high myo-inositol diet. American Journal of Clinical Nutrition 1980;33:1954-67.
10. Cohen P. The twentieth century struggle to decipher insulin signalling. Nature Reviews. Molecular Cell Biology 2006;7:867-73.
11. Crawford TJ, Crowther CA, Alsweiler J, Brown J. Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD011507.pub2]
12. Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine 2005;352:2477-86.
13. Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 2013;95(10):1811-27.
14. D'Anna R, Di Bendetto V, Rizzo P, Raffone E, Interdanto ML, Corado F, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecological Endocrinology 2012;28(6):440-2.
15. Ferrara A. Increasing prevalence of gestational diabetes mellitus. Diabetes Care 2007;30(Suppl 2):S141-S146.
16. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovarian syndrome. Gynecological Endocrinology 2008;24:139-44.
17. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
18. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676-82.
19. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-8.
20. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicentre, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine 2009;361(14):1339-48.
21. Larner J, Brautigan DL, Thorner MO. D-chiro-inositol glycans in insulin signaling and insulin resistance. Molecular Medicine 2010;16(11-12):543-51.
22. McCance DR. Pregnancy and diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 2011;25:945-58.
23. McCurdy C, Friedman J. Mechanisms underlying insulin resistance in human pregnancy and gestational diabetes mellitus. In: Kim K, Ferrara A editor(s). Gestational Diabetes During and After Pregnancy. London: Springer, 2010:125-38.
24. Metzger BE, Coustan DR. Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21 (Suppl. 2):B1-B167.
25. Minozzi M, D'Andrea G, Unfer V. Treatment of hirsutism with myo-inositol: a prospective clinical study. Reproductive Biomedicine Online 2008;17(4):579-82.
26. Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, et al. for the Australasian Diabetes in Pregnancy Society (ADIPS). Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia. URL: http://adips.org/downloads/ADIPSConsensusGuidelinesGDM-03.05.13VersionACCEPTEDFINAL.pdf (accessed 03 July 2015).
27. New Zealand Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington, New Zealand: Ministry of Health, 2014.
28. National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-conception to the Postnatal Period. Manchester: NICE, 2015.
29. Nordio M, Pajalich R. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. Journal of Thyroid Research 2013;2013:Article ID 424163. [DOI: 10.1155/2013/424163]
30. Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, et al. Myoinositol in patients with polycystic ovarian syndrome: a novel method for ovulation induction. Gynecological Endocrinology 2007;23:700-3.
31. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
32. Saltiel AR. Second messengers of insulin action. Diabetes Care 1990;13(3):244-56.
33. The HAPO Study Cooperative Research Group. Hyperglycaemia and adverse pregnancy outcomes. New England Journal of Medicine 2008;358(19):1991-2002.
34. Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecological Endocrinology 2011;27:857-61.
35. Wang Z, Kanguru L, Hussein J, Fitzmaurice A, Ritchie K. Incidence of adverse outcomes associated with gestational diabetes mellitus in low- and middle-income countries. International Journal of Gynecology and Obstetrics 2013;121:14-9.
36. Wendland E, Torloni M, Falavigna M, Trujilo J, Dose MA, Campos MA, et al. Gestational diabetes and pregnancy outcomes: a systematic review of the World Health Organization (WHO) and the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy and Childbirth 2012;12:23.
37. West NA, Crume TL, Maligie MA, Dabelea D. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia 2011;54(3):504-7.